Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition

[1]  W. Ahrens,et al.  Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention , 2020, Current Obesity Reports.

[2]  M. Guida,et al.  Metabolomics in endometrial cancer diagnosis: a systematic review. , 2020, Acta obstetricia et gynecologica Scandinavica.

[3]  V. Viallon,et al.  Prospective analysis of circulating metabolites and breast cancer in EPIC , 2019, BMC Medicine.

[4]  M. A. Siddik,et al.  Recent Progress on Branched-Chain Amino Acids in Obesity, Diabetes, and Beyond , 2019, Endocrinology and metabolism.

[5]  Á. Gil,et al.  Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies , 2019, Metabolomics.

[6]  S. Ab-Rahim,et al.  Global serum metabolomics profiling of colorectal cancer , 2019, Molecular and clinical oncology.

[7]  M. Laakso,et al.  Nine Amino Acids Are Associated With Decreased Insulin Secretion and Elevated Glucose Levels in a 7.4-Year Follow-up Study of 5,181 Finnish Men , 2019, Diabetes.

[8]  M. Gunter,et al.  Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions , 2018, Nature Reviews Gastroenterology & Hepatology.

[9]  L. Ferrucci,et al.  Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults , 2018, The Journal of clinical endocrinology and metabolism.

[10]  M. Ezzati,et al.  Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment , 2018, The lancet. Diabetes & endocrinology.

[11]  V. Viallon,et al.  Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case–Control Study in EPIC , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[12]  J. Troisi,et al.  Metabolomic Signature of Endometrial Cancer. , 2018, Journal of proteome research.

[13]  L. Galluzzi,et al.  Mitochondrial metabolism and cancer , 2017, Cell Research.

[14]  J. Wardle,et al.  The Impact of Diet‐Induced Weight Loss on Biomarkers for Colorectal Cancer: An Exploratory Study (INTERCEPT) , 2017, Obesity.

[15]  Mimi Y. Kim,et al.  Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[16]  P. Vineis,et al.  Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort. , 2017, Journal of proteome research.

[17]  David M. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[18]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[19]  M. Hendryx,et al.  Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[20]  F. Tinahones,et al.  Metabolomics‐guided insights on bariatric surgery versus behavioral interventions for weight loss , 2016, Obesity.

[21]  F. Tinahones,et al.  Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[22]  Farshad Farshidfar,et al.  A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics , 2016, British Journal of Cancer.

[23]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[24]  T. Pischon,et al.  Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam study , 2016, Nutrition & Diabetes.

[25]  L. Brennan,et al.  Metabolomics as a tool in the identification of dietary biomarkers , 2016, Proceedings of the Nutrition Society.

[26]  E. Riboli,et al.  A Nested Case–Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2016, PLoS medicine.

[27]  H. Boeing,et al.  Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study , 2016, BMC Medicine.

[28]  Adrian V. Hernández,et al.  Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis. , 2015, European journal of cancer.

[29]  Paolo Vineis,et al.  A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study. , 2015, Mutagenesis.

[30]  N. Mode,et al.  Validity of self-reported body mass index among middle-aged participants in the Norwegian Women and Cancer study , 2015, Clinical epidemiology.

[31]  Eun-Kyoung Kim,et al.  A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes , 2015, Molecules and cells.

[32]  Thiago I. B. Lopes,et al.  Blood Metabolome Changes Before and After Bariatric Surgery: A (1)H NMR-Based Clinical Investigation. , 2015, Omics : a journal of integrative biology.

[33]  T. Rohan,et al.  Breast cancer risk in metabolically healthy but overweight postmenopausal women. , 2015, Cancer research.

[34]  M. Singer,et al.  Metabolic Health Reduces Risk of Obesity-Related Cancer in Framingham Study Adults , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[35]  E. Riboli,et al.  Investigating sources of variability in metabolomic data in the EPIC study: the Principal Component Partial R-square (PC-PR2) method , 2014, Metabolomics.

[36]  F. Clavel-Chapelon,et al.  Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. , 2014, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[38]  Bryan C. Batch,et al.  Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss , 2012, Diabetologia.

[39]  J. Fechner,et al.  An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells , 2010, The Journal of Immunology.

[40]  J. H. Lee,et al.  Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). , 2010, Journal of proteome research.

[41]  F. Clavel-Chapelon,et al.  Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.

[42]  Li Li,et al.  Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[44]  C. Friedenreich,et al.  Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[45]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[46]  C. González,et al.  The European Prospective Investigation into Cancer and Nutrition (EPIC) , 2004, Public Health Nutrition.

[47]  I. Gram,et al.  Fruits and vegetables and lung cancer: Findings from the European prospective investigation into cancer and nutrition , 2004, International journal of cancer.

[48]  E. Gabazza,et al.  Oxidative stress is associated with adiposity and insulin resistance in men. , 2003, The Journal of clinical endocrinology and metabolism.

[49]  Jo Mitchell,et al.  Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study , 2003, Public Health Nutrition.

[50]  F. Clavel-Chapelon,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics , 2002, Public Health Nutrition.

[51]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[52]  T. Key,et al.  Validity of self-reported height and weight in 4808 EPIC–Oxford participants , 2002, Public Health Nutrition.

[53]  H. Boeing,et al.  Follow-Up Procedures in EPIC-Germany – Data Quality Aspects , 1999, Annals of Nutrition and Metabolism.

[54]  C. O’Flanagan,et al.  Molecular and metabolic mechanisms underlying the obesity-cancer link , 2018 .

[55]  H. Boeing,et al.  [The importance of the common cancer registry for the identification of cancer cases in the EPIC Potsdam-study -- results of the first record linkage]. , 2004, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[56]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[57]  H Boeing,et al.  Interviewer variability in anthropometric measurements and estimates of body composition. , 1997, International journal of epidemiology.

[58]  M. Ocké.  European prospective investigation into cancer and nutrition. Voedingsnavraag in de EPIC studie. , 1996 .